Skip to content

Clinical trials

Trials in Mexico with no applicable phase and unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Not applicable Status: Unknown status Country / region: Mexico Clear all

207 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20093
20102
20111
20124
20133
20145
201510
201613
201715
201825
201920
202022
202124
202221
202323
202415

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status207

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran18
Instituto Nacional de Cardiologia Ignacio Chavez11
University of Guadalajara10
Hospital General de Mexico7
Coordinación de Investigación en Salud, Mexico6
Instituto Mexicano del Seguro Social6
Hospital Universitario Dr. Jose E. Gonzalez5
Instituto Nacional de Enfermedades Respiratorias5
Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes5
Universidad Nacional Autonoma de Mexico5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity20
Anxiety Disorders13
Diabetes Mellitus, Type 211
Overweight7
Diabetes Mellitus6
Metabolic Syndrome6
Pain6
Weight Loss5
COVID-194
Coronary Artery Disease4

Trials

Showing 1 to 25 of 207. Each trial links to its page on Pharma Observatory.

107 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.